Penumbra, Inc (NYSE: PEN) is a U.S.-based medical device company focused on interventional therapies for stroke and vascular conditions. Its portfolio includes thrombectomy devices and neurovascular access technologies, alongside an emerging presence in immersive healthcare rehabilitation. Penumbra offers investors high-growth medtech exposure and product innovation in life-saving treatments.
最新股票文章

平頭哥分拆上市分析:阿里巴巴AI芯片業務的結構性風險與估值框架
阿里巴巴旗下平頭哥半導體擬分拆獨立上市,摩根大通估值介於250億至620億美元。本文從業務依賴度、估值方法論、地緣政策風險及港股科技板塊估值溢價等維度,解構該交易的結構性風險與分析框架。
14:16, 11 3月 2026


